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Background: Numerous information models for electronic health records, such as openEHR archetypes are
available. The quality of such clinical models is important to guarantee standardised semantics and to facilitate their
interoperability. However, validation aspects are not regarded sufficiently yet. The objective of this report is to
investigate the feasibility of archetype development and its community-based validation process, presuming that
this review process is a practical way to ensure high-quality information models amending the formal reference
model definitions.
Methods: A standard archetype development approach was applied on a case set of three clinical tests for
multiple sclerosis assessment: After an analysis of the tests, the obtained data elements were organised and
structured. The appropriate archetype class was selected and the data elements were implemented in an iterative
refinement process. Clinical and information modelling experts validated the models in a structured review process.
Results: Four new archetypes were developed and publicly deployed in the openEHR Clinical Knowledge Manager,
an online platform provided by the openEHR Foundation. Afterwards, these four archetypes were validated by
domain experts in a team review. The review was a formalised process, organised in the Clinical Knowledge
Manager. Both, development and review process turned out to be time-consuming tasks, mostly due to difficult
selection processes between alternative modelling approaches. The archetype review was a straightforward team
process with the goal to validate archetypes pragmatically.
Conclusions: The quality of medical information models is crucial to guarantee standardised semantic
representation in order to improve interoperability. The validation process is a practical way to better harmonise
models that diverge due to necessary flexibility left open by the underlying formal reference model definitions.
This case study provides evidence that both community- and tool-enabled review processes, structured in the
Clinical Knowledge Manager, ensure archetype quality. It offers a pragmatic but feasible way to reduce variation in
the representation of clinical information models towards a more unified and interoperable model.
Keywords: Electronic health records, Multiple sclerosis, Medical documentation, Information models, ArchetypesBackground
Introduction
There is a desideratum that high-quality clinical informa-
tion models should be key parts of electronic health re-
cords (EHRs) [1], as they form reusable semantic artefacts
[2,3]. Several standards have been created to represent
and exchange electronic health data [4-6]. Among the
most prominent approaches there are Health Level Seven
(HL7) [7], openEHR [8,9], and its subset the European* Correspondence: michael.braun@uniklinik-freiburg.de
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unless otherwise stated.and ISO Standard 13606 (Health informatics – Electronic
health record communication) [10,11]. These standards
meet two key requirements for EHRs: syntactic interoper-
ability and semantic interpretability. The systems should
interoperate on the data level, as well as on the level
of intended clinical meaning [1]. Whereas HL7 CDA
(Clinical Document Architecture) is a widely adopted
standard to document clinical information, openEHR
has advantages in modelling what had been termed clin-
ical concepts [12,13]. The Clinical Information Modelling
Initiative (CIMI) also uses the openEHR approach [14].
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the representation of semantically interoperable health
information. In an openEHR context the term clinical
concepts does not signify entities of meaning like in ter-
minologies or ontologies, but structured sets of data items
to be recorded in a clinical context, e.g. for a specific clin-
ical situation such as blood pressure or body weight obser-
vation. Numerous openEHR models have been developed.
Several hundreds of them are freely accessible through-
out online repositories, such as the Clinical Knowledge
Manager (CKM) [15], provided by the openEHR Foundation
[16], a not-for-profit company founded by the University
College London (UK) and Ocean Informatics (Australia).
OpenEHR utilises a modelling approach specifying the
information required to document any given clinical situ-
ation as a computable expression of a domain content
model, called archetype [17-20]. In ISO 13972, similar con-
structs are named Detailed Clinical Models. Archetypes
are reusable formal clinical models. They are expressed
as a computable set of constraints based on a reference
model. Typical clinical situations to be documented using
archetypes include blood glucose measurements, diagnosis,
microbiology results, medication, and adverse reactions.
An archetype specifies all the information a clinician
might want to report about a particular clinical scenario
[21]. However, there is no formal or quantitative correct-
ness or completeness measure for archetype content.
Formal criteria, indicators or patterns upon which some
sort of comparison could be based on are lacking. Even
though a reasoning method for validation based on the
Web Ontology Language (OWL) was proposed [14],
which can help to detect inconsistencies, it is not pos-
sible to compute their quality automatically. Although
archetype-based EHRs exchange formalised clinical data,
“there is a risk that mistaken interpretations may lower
the accuracy of the communicated record and negatively
impact on the quality of medical care” [3]. Also, the qual-
ity of the interfaces derived from those models like arche-
types may have a direct impact on the quality of data in
the future clinical use [22,23]. Improved user-interface de-
sign can offer lower interface error rates [24]. However,
most of the archetypes are still in draft status, which mean
that their quality assessment, to be examined in a standar-
dised review process provided by the openEHR Founda-
tion, is still pending. Until now, only few archetypes have
been internationally peer reviewed by domain experts and
received published status (as a visible sign).
Not many publications focus on the development of ar-
chetypes [3]. In [25] the immaturity of the openEHR ap-
proach and the available modelling tools is criticised. It
states that developing high-quality archetypes is challen-
ging and complex, archetypes do sometimes overlap, and
the search for appropriate archetypes is time-consuming.
According to [26], the design of archetype systems is nottrivial, but archetypes are suitable to solve the problem of
EHR storage and interoperability.
Objective
The objective of this work is to thoroughly describe a case
report about the openEHR development and validation
process. Of particular interest is hereby the modelling
process, including a review to validate archetype content.
This open community-based approach is a unique feature
of openEHR and has not been described before in such
detail.
Furthermore, we wanted to discuss whether the arche-
type team review process can improve the semantic qual-
ity of archetypes beyond what is formally defined by the
underlying openEHR reference model. We anticipate the
openEHR team review process as a feasible way for valid-
ating archetypes and augmenting their semantics.
Our scenario has been the Multiple Sclerosis Functional
Composite (MSFC) [27], a performance scale for the as-
sessment of Multiple Sclerosis (MS) patients consisting of
three neurological tests. Of further interest was hereby the
suitability of archetypes for representing complex hetero-
geneous clinical tests. In particular, we traversed the work-
flow for the development and validation of archetypes
regarding its practicability.
Background and significance
Background of the openEHR approach
It requires established standardised medical information
model specifications to ensure interchangeability and re-
usability of EHRs. The openEHR Foundation provides
such specifications in the form of archetypes [28,29]. The
two-layered modelling approach of openEHR allows clin-
ical information to be specified in distinct models, called
archetypes [18]. They provide the building blocks of infor-
mation systems: syntactic interoperability and semantic
interpretability [30]
In this two-layered approach, a repository based on a
stable reference model, the first layer (see paragraph
below), contains just generic knowledge and business rules
[31]. So-called clinical knowledge, i.e. specifications of what
is to be recorded by the model, is stored separately in the
Archetype Model, which constitutes the second layer (see
second paragraph below). This improves the flexibility of
resulting EHR systems, because changes in the clinical
knowledge can be dealt with only by revising archetypes,
without compromising the integrity of information in the
reference model [31].
The Reference Information Model defines a stable set of
building blocks (modelling patterns), upon which the clin-
ical models (archetypes) are specified. It includes complex
data types, information patterns (e.g. entities called data,
qualifier, state) and structural parts (e.g. composition, entry,
tree) [31]. The clinical models are defined by constraining
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to be invariant in the long term, which minimises the need
for schema and software updates [32].
The Archetype or Knowledge Model is the backbone of
the openEHR architecture. An archetype “is the model
(or pattern) for the capture of clinical information – a
machine readable specification of how to store patient
data using the openEHR Reference Model” [31]. Each
archetype comprehensively describes the information to
be collected in a certain clinical record. These discrete
models are intended to be directly instantiated with pa-
tient data in the clinical information system [31].
There are three different categories of archetypes, each
corresponding to classes in the openEHR reference model:
Thematic archetypes of Compositions, which correspond
to commonly used clinical documents. Organisational ar-
chetypes of Sections assist human navigation within EHRs.
Entries are the most common and fundamental building
blocks of EHRs. There are four different classes of these
descriptive archetypes in the openEHR reference model
to represent different kinds of clinical data: Observation
(e.g. to record measurable or observable data), Evaluation
(e.g. to record clinical findings), Instruction (e.g. to record
the initiation of a workflow process), and Action (e.g. to
record clinical activities) [31].
The content of archetypes should ideally be language-
independent, so that they can be translated, interpreted,
and viewed in another language without losing meaning
or context [31]. This is ideally assured if their meaning-
bearing elements are bound to a multilingual termino-
logical standard like SNOMED CT, which provides a clear
model of meaning by well-defined concepts and attached
terms in different languages. Archetypes can be assembled
and specialised to form compositions in the EHR for a spe-
cific clinical purpose, called templates [33]. These aggrega-
tions can form data sets corresponding to clinical tasks,
such as antenatal exams or discharge summaries [9].
Projects and applications utilising openEHR archetypes
There are numerous projects utilising openEHR archetypes.
A literature review of archetype-based EHRs is available in
[26]. It gives an overview about worldwide archetype use
and archetypes for electronic decision support systems.
An editor that supports manual and semi-automatic cre-
ation of bindings between archetypes and terminology sys-
tems is presented in [34]. Not only finding correct terms is
difficult [34]; another challenge is the boundary problem
between archetypes and terminologies [26]: what should
be represented in the archetype, what in the terminology?
Various EHR approaches, including HL7 and openEHR,
are evaluated in [5] versus the Generic Component Model
(GCM), a reference architecture for providing a multi-
model approach to any system architecture. Reflecting all
GCM paradigms is demanded as crucial. The formalisationof most of the approaches is criticised as “underdevel-
oped”. HL7 has the largest intersection with the GCM, but
many specifications are still inconsistent. The ontology-
driven architecture [35,36] of the openEHR approach is
valued in particular. However, no meta-model was found
in the openEHR system architecture [5].
The expression of clinical data sets (CDS) for paediat-
ric oncology with openEHR archetypes was investigated
in [37]. 48 archetypes were developed and it was stated
that they are of better quality than original CDS (they
came across CDS problems and openEHR-based solu-
tions). The conclusion was that archetypes are a robust
base for ubiquitous computing. The approach is feasible
and semantically interoperable, but unable to overcome
all barriers.
Archetype modelling strategies
The formal language to express openEHR archetypes is
the Archetype Definition Language (ADL). It provides
syntax for describing constraints on information entities
whose data is described by the reference model. Although
there is a rich set of specifications for the modelling lan-
guage itself and the general architecture available, not
much information about the actual modelling process is
given. A set of 14 general “Archetype Design Principles”
[18] is available and a tutorial on building archetypes [38].
In addition, on the openEHR webpages certain informa-
tion is available about how to choose the right class for
the archetype and other frequently asked questions. In
sum, this is not much source for developing high-quality
archetypes, rather a starting point for beginners. There-
fore, the development of a first archetype is not a straight-
forward task.
Application domain: the Multiple Sclerosis Functional
Composite
The MSFC is a standardised quantitative assessment in-
strument for clinical practice and research on Multiple
Sclerosis (MS). The US National Multiple Sclerosis Society
originally developed it for the application in clinical tri-
als. An administration and scoring manual is publicly
available [27].
The well-established and widely used MSFC consists
of three separate neurological tests, which are important
for the diagnosis of MS. The cognitive and motor skills of
patients are assessed by the following tests:
1. The Timed 25-Foot Walk (T25FW) is a quantitative
walking test of lower extremity function.
2. The Nine Hole Peg Test (NHPT), a quantitative
measure of upper extremity function, is used for
rapid assessment of a subject’s finger dexterity.
3. The Paced Auditory Serial Addition Test (PASAT)
measures the cognitive function. It specifically
Figure 1 Development steps for building a new archetype. If
no existing archetype can be reused, the shown steps should be
performed, based on [38].
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and flexibility, as well as the calculation ability of
patients.
The results of three separate tests are settled as a total
value (the MSFC Score), which correlates with the sever-
ity of the disease with respect to a reference population.
The average result of each test is individually computed
to a Z-score and averaged in the MSFC Score. All three
measures making up the MSFC showed to have good
inter-rater and test-retest reliability [39].
Methods
Archetype modelling
The procedure models mentioned follow similar major
steps, with varying levels of detail: At the beginning, an
analysis of the data to be represented is performed. In
the following step(s), the data obtained is organised and
structured. After choosing the appropriate archetype class,
the data fields (structure, meta-information, constraints
etc.) are implemented. As archetypes are usually devel-
oped in a team, an iterative refinement process is suitable.
The authoring group consisted of two physicians (one a
clinical MS expert but with no modelling experience, the
other one a medical informatics expert with no MS ex-
pertise but with modelling experience), two technicians
and one modelling expert (although with no previous ex-
pertise in archetype modelling).
OpenEHR archetypes are very flexible and expressible
models. The approach is open to deal with any possible
scenario and for interoperability. It offers just a general
methodology, leaving a lot of flexibility (regarding struc-
ture etc.) to the modellers. This means that for many de-
sign decisions there are no formal constraints, making
some selections decisions difficult. Instead of narrowing the
selection decisions down (and risking to lose expressive-
ness), they implemented for a governance review process to
ensure consistency and quality of the resulting model (see
corresponding section after the archetype development as
well as in the discussion).
Developing archetypes for the MSFC
An individual archetype was developed for each of the
three MSFC tests: Timed 25-Foot Walk, Nine Hole Peg
Test and Paced Auditory Serial Addition Test. In addition,
one archetype representing theMSFC Score was modelled.
We used the current stable release ADL 1.4 [28]. The fol-
lowing methodology was used for each of the four arche-
types, a modified approach of [38], see Figure 1:
At first, an analysis of the domain of discourse and the
requirements was performed. The developer of an arche-
type should be deeply informed about the entity he wants
to represent. Usually, it will be necessary to involve do-
main experts in the modelling process. In our case, this
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analysis of their record forms and administration instruc-
tions. One major principle of archetypes is that they
should represent a maximum dataset [31,38] to maximise
reuse and interoperability [35]. Therefore, all attributes
clinicians might want to capture in a given scenario have
to be identified.
Sometimes the instructions about how a test has to be
administered are contradictory, like in the case of the
Nine Hole Peg Test [27,40,41]. We always took the
MSFC Manual as reference, but also covered variants of
the test. Ambiguous topics, as well as test variants (ne-
cessary to maximise reuse) can lead to time-consuming
modelling decisions.
As part of the analysis, a search for existing archetypes
should be performed with the aim to reuse them. There
are publicly accessible repositories such as the openEHR
CKM. If no existing archetype can be adapted or reused,
a new one has to be developed. We decided to design
new archetypes, because we did not retrieve reusable ar-
chetypes on the internet or in openEHR repositories.
For each new archetype, the content was gathered, orga-
nised, and structured: The relevant items were identified
from books, instruction manuals, record forms, and journal
articles. Examples include the time needed to complete the
25-foot walk, the number of correct answers for addition
test and confounding factors in all tests. The archetype
header also includes a list of the references that were used
to gather the content of the archetype, also demanded in
[1]. After identifying the relevant content, organisation in
mind maps is useful for further discussion including med-
ical experts [3].
With the selection of the appropriate class of the arche-
type (the next step), the content was structured further, ac-
cording to the specific class. Every class has a different
structure and specific attributes for different parts of the
clinical recording processes and workflow. As we record
measurable data, the Observation class fits for all of the
four MSFC archetypes. This class is structured into Data,
Events, Protocol, and State. The Data part contains the core
information (e.g. the MSFC score, the percentage of cor-
rect answers, or information when the trial was not com-
pleted and the reasons therefore). The Event part contains
information about the timing of the observation. The
Protocol part contains information on how the informa-
tion was gathered or measured (e.g. if multiple attempts
were needed to complete the task or which assistive de-
vices were used). The State part contains information
about the patient at the time when the information was
collected, in our cases especially confounding factors for
administering the tests. This information is important for
the interpretation of the core information recorded in data.
After the selection of the appropriate class of the arche-
type, the actual implementation began: The archetype wasnamed, structures were selected, and meta-information
was given, including keywords, author, and contact infor-
mation. Also required by [1] and already part of the ADL,
copyright and version information were added auto-
matically by the editing tool (see second paragraph below).
Then we added the data elements with appropriate data
types and descriptions. Occurrences and constraints were
defined where necessary. Giving concise definitions of each
concept, the purpose, use and misuse of the archetype, as
well as setting appropriate constraints are challenging tasks
that require a lot of coordination effort and expert opinion.
This applies for both the development phase and on the
review process.
In order to streamline the development process, we
did not realise terminology bindings [34], i.e. connection
to representational units in SNOMED CT, LOINC, ICD,
or other terminology systems. We consider terminology
bindings or, more generally, semantic annotations of arche-
type elements [42], as well as translations, as separate,
non-trivial tasks. The binding of terminology codes is diffi-
cult to perform due to the large size of the terminologies
[43]. Therefore, we focussed on the content review (next
sections) and we will add terminology bindings in the fu-
ture. We leave open whether this two-step approach is rec-
ommendable in all cases. There might be good reasons to
perform terminology binding in an early step of archetype
construction in order to prevent further misunderstand-
ings by an unconscious choice of ambiguous terms.
During the whole process, we followed an iterative ap-
proach. We discussed the current state of development
in regular intervals with medical experts and our project
partners. A few times consensus was not reached during
a meeting. Then further investigations were required to
elaborate further on the benefits or weaknesses of differ-
ent approaches. Usually, the questions were resolved in
the following meeting. The general principle was to repre-
sent the existing record forms of the tests as precise as
possible. We used the Archetype Editor as modelling tool,
which is publicly available from openEHR and Ocean In-
formatics. This editor offers a graphical user interface that
supports creating and editing openEHR archetypes on the
client side. Authoring is supported by an intuitive drag-
and-drop interface. Generated GUI mock-ups help users
to visualise the meaning of the archetypes. Translations
and bindings to terminologies can also be added using the
Archetype Editor.
Validation
Archetype design and validation can be time-consuming
due to the lack of both domain expertise and modelling ex-
perience. There are two aspects of validation: syntactical
and content validation. Technical aspects, such as syntax
checking etc. can be covered easily by tools, like the Clinical
Knowledge Manager or the ADL Workbench [44]. The
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ADL Workbench and the CKM. In addition, the models
were checked and found to be correct by the online
OWL-based reasoning tool Archeck, introduced in [14].
Furthermore, actual archetype content validation is cru-
cial as well [23]. For example, there is not always a sharp
separation in choosing the right data types or structuring
content. It is also arguable what “right” means. Only clin-
ical domain experts as well as modelling experts together
can give advice and form consensus during review [45].
In order to upload, review, and publish the resulting four
MSFC archetypes to the CKM, we contacted the leading
editors of openEHR. Before the actual review process in
the CKM (following section) we performed an informal in-
ternal check of the archetypes to meet certain (coding)
conventions and had some improvements addressing their
form, rather than modifying content.
The team review process
The four MSFC archetypes were reviewed by international
clinical and domain experts. The openEHR Archetype
Team Review is a straightforward tool-based process in
the CKM. This platform serves as archetype repository
and revision control system, as well as a foundation for
the review supporting and structuring the whole process.
The review is based upon volunteers, who can participate
after registration in the platform, affiliated or not affiliated
with openEHR (not members of any openEHR committee)
likewise. Registration is open to everyone who is interested
in archetype usage, modelling, translation, and revision.
We applied the review process to the four archetypes,
which is described as follows: The archetypes were initially
uploaded where they automatically received Draft status.
Then the process was initiated, and a review team was in-
vited: Reviewers could be picked manually as well as via a
search function, e.g. all CKM users with clinical expertise
in Neurology and willing to volunteer in reviews were
chosen. The team included reviewers affiliated and not af-
filiated with openEHR from universities, companies, and
hospitals likewise. They received an invitation with a short
description of the respective archetype, the CKM process,
and a review checklist [46]. During the review, archetypes
were flagged as Team review.
The review itself consisted of multiple iterations, called
review rounds. Periods for the participation in and the
completion of the review were given (typically two weeks).
Reviewers could comment every aspect of the archetype.
They should examine all items critically. This includes, but
is not limited to concept names and descriptions, appropri-
ate date types and structure, constraints and cardinalities,
missing items and metadata. The archetype under review
should also be checked for consistency of phrasing, expres-
sion, punctuation, and spelling. A comprehensive checklist
is available in [46]. During this process, the reviewers canaddress questions and discuss every aspect of the model,
like revising descriptions, adding record examples, clarify-
ing meta-information, or adding constraints. The editors
can also post specific questions to request expert opinion
for certain modelling decisions.
To conclude the round, the reviewers gave an overall rec-
ommendation of the archetype (Accept, Minor Revision,
Major Revision, Reject, or Abstain). At the end of each
round, all comments were collected and a summary was
written. The archetypes were checked out for changes and
modified according to the reviewers’ comments and sugges-
tions. After performing the changes, the archetypes were
uploaded again and a check-in into the CKM versioning
system was done. The reviewers received a summary about
the changes, and then the editors initiated the next review
round. The models were refined with each round. When
consensus was reached and all the reviewers’ requests
were met, the archetypes received published status.
Results
In this work, we created four new archetypes representing
the MSFC neurological test suite. All archetypes are avail-
able in English and German. They are of the Observation
class, as they represent measurable test results. The arche-
types were internationally reviewed by domain experts
and published. All four models are publicly accessible on
the internet in the CKM directly via the links below (with-
out registration). They are available free of charge for or-
ganisational and individual use under Creative Commons
Attribution-ShareAlike 3.0 Unported License (CC BY-SA
[47], the same as e.g. Wikipedia):
 Timed 25-Foot Walk: http://www.openehr.org/ckm/
#showArchetype_1013.1.1200
 Nine Hole Peg Test: http://www.openehr.org/ckm/
#showArchetype_1013.1.1202
 Paced Auditory Serial Addition Test: http://www.
openehr.org/ckm/#showArchetype_1013.1.1296
 MSFC Score: http://www.openehr.org/ckm/
#showArchetype_1013.1.1368
Figure 2 shows the mind map representation of the
Timed 25-Foot Walk archetype. It illustrates the structure
of the Observation class: Data, Events, Protocol and State,
as well as Description for meta-information. This points
out that there are many possibilities for structuring the
data elements. All data elements and their type (e.g. Text,
Boolean, Time) are visible but not their description or
additional constraints.
The parts mentioned cannot always be differentiated
precisely, especially between Data, State, and Protocol.
In the beginning, it is not always clear whether a certain
item (i.e. the dominant hand in the peg test) belongs to
the core data that is observed, to the patient’s state, or
Figure 2 The mind map representation of the Timed 25-Foot Walk archetype. This figure is extracted from the CKM and shows the
structure of the Observation class and the data elements of the archetype.
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different medical experts might have different opinions.
Therefore, this structuring process requires coordin-
ation effort with experts in the field, which can be time-
consuming. This applies for both, the modelling phase
and the later review process as well. Every detail of the ar-
chetypes can be seen in CKM via the links above. There-
fore, we abstain to describe the resulting final models in
details. CKM offers multiple sights on the models, like the
mind map overview (as above), a detailed view of every
concept description, and an ADL as well as an XML rep-
resentation. The archetype history and review status is
transparent online in the CKM.
Table 1 shows the metrics of the archetype review
process, viz. how much feedback was received, and how
many people were involved in the model refinement.Table 1 Metrics from the reviews of the four MSFC archetype
Archetype Timed 25-Foot Walk Nine Hole Peg
Data elements 20 28
Review rounds 3 2
Reviewer 8 5
Reviews (total) 14 8
Comments (total) 41 27
Change requests 42 29
Individual requests 31 26
Changes implemented 27 21
Contributors 11 10The first line shows the number of data elements of
each archetype. It did not change during the reviews
in all four archetypes. The second line shows the number
of review rounds needed until publication, followed by the
number of single reviewers that participated, and the
number of total reviews for each archetype. The fifth line
shows the total number of comments given in all review
rounds. From the reviewers’ comments, we identified a
number of change requests for the archetypes. Some of
them occurred more than once, so the number of indi-
vidual change requests is shown in the next line. The
final line shows the overall number of individuals who
contributed to the development and publication of each
archetype.
We generally demonstrated that the openEHR ap-
proach is an adequate format for representing complexs
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detail as archetypes. However, the question arises to the
expert quality and the validity of the models. Most, but
not all of the reviewers’ requests were met, mainly because
of different understanding of the test instructions or align-
ment with modelling conventions. These issues were dis-
cussed and resolved online during the process. Most
changes were of textual matter (clarifying descriptions,
changing options, or giving examples) or adding/removing
constraints. A more comprehensive survey, i.e. with the
number of reviews in each round and the reviewers’ rec-
ommendations can be seen online in CKM for each arche-
type, including its revision history. Single comments of
the reviewers are visible only for editors and the other re-
viewers. Apart from that, the process is highly transparent.
Altogether, we proceeded sequentially and finished one
archetype review before we initiated the next. Hence, the
experiences from the previous reviews were incorporated
in minor revisions of the following models. For example,
some data elements (like confounding factors) appear in
several archetypes. This may be a reason why later review
rounds were shorter, because the quality of models was
more elaborated at the beginning of the development
process. The time from first review round initiation date
to latest review round completion date took an average of
59.5 days (with a range 14–122 days). For the other eight
archetypes that have received published status in CKM
by then, the average period was even longer with 180
(40–323) days. These numbers intended as a rough guide
making the interpretation difficult due to the small data
pool. It is also difficult to generalise these numbers to dif-
ferent topics. The time needed depends in particular on
the subject to be mapped, how structured and ambiguous
it is, as well as on the team size and its experience. Further
problems are the periods of idle time in the overall process.
However, the CKM turned out to be a sophisticated col-
laborative platform, which helps to organise reviews as
straightforward processes. On this basis, archetype refine-
ment and content validation were conducted on a high-
qualitative level.
Discussion
In this work, we have presented four new archetypes for
the MSFC. We have focussed on the development and
validation process itself, which has not been described
in detail before. The interface of the publicly available
Archetype Editor supports the development process visu-
ally. However, the archetype development process was slo-
wed down due to difficult selection decisions between
alternative modelling approaches, also reported in [3]. All
four archetypes were uploaded to the CKM, where they
are publicly accessible. After validation by domain experts
in the community-based review process, they received
published status. Structured by the CKM, archetype reviewis a straightforward and well-organised team process with
the goal to validate archetypes pragmatically. In this case
report we provide evidence for the quality improvement of
information by this community effort. We emphasise that
content validation is crucial for quality enhancement and
standardisation of openEHR information models, where a
corresponding formal model must have its shortcomings
to preserve the necessary flexibility.
Due to the lack of formal or quantitative correctness
measurements for archetypes, the only way of assessing
and improving the model quality is peer review by do-
main experts. This process ensures not only the quality
of the models themselves, but also their acceptance by
other clinical experts. Despite the wide agreement on
the importance of the reviews (e.g. [45,48,49]), less than
5% of the CKM archetypes have been reviewed and re-
ceived published status today. Significant further work
needs to be done in order to ensure interoperable high-
quality archetypes [1]. We hope that the presented work
can lower the barrier for developers to request a formal
review with the openEHR community. Only then, a suf-
ficient foundation of validated archetypes will be publicly
available and analyses with more numerous cases can be
performed.
This also leads to the question whether the archetypes
in draft state available in the CKM are “safe” to use or re-
use (modelling step 2) in contrast to reviewed archetypes
in published state. Before new archetypes are uploaded,
they undergo an editorial appraisal to ensure a certain
standard (mentioned earlier). CKM users are not permit-
ted to upload new archetypes, only CKM editors can do
this. Still, the quality of these archetypes may vary widely.
They can be a starting point for review or may be in a
state close to publication.
Once uploaded and online in the CKM, every user can
comment any archetype and address e.g. missing aspects,
different or country-specific views without formal review.
The editors can then incorporate or discuss the change re-
quests. But neither this nor the editorial check before up-
load can substitute a formal review by domain experts of
the community. The audience is wider, as more people are
involved and much more viewpoints are considered in the
discussion.
A lot of archetypes are online for some years and some of
them have received suggestions for improvement continu-
ously. So they may have matured over time, even though
the formal standard review is lacking. However, there may
be indicators for the maturity of a draft archetype, like its
history and revision, the number of contributors etc., but
not a formal assessment. Based on the experience with our
own archetypes, we advise to take a close look at archetypes
in draft state. The potential user should be aware that the
review could lead to significant changes. Hence, we do not
recommend using draft archetypes in a clinical setting.
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was affected by the domain of discourse. However, we do
not believe that our setting (the MSFC) had an impact on
the general illustration of the design and validation process
(the steps performed are independent of the use case). The
degree of formalisation and standardisation of the domain
as well as of the material that is available as reference will
indeed influence the process (e.g. more complex models
may require more coordination effort).
Madsen et al. investigated sustainable clinical know-
ledge management with respect to the archetype devel-
opment life cycle. A well-designed archetype for a given
clinical entity should cover all of the data, independent
of the use-case [35]. They proposed a process for archetype
development with seven phases, related to the traditional
software development lifecycle. The first phase is the plan-
ning phase, where the content is gathered from various
sources and clinicians are engaged to ensure alignment
with clinical requirements. The analysis phase includes data
analysis and consolidation as well as inspection of existing
archetypes. Following the requirement specification phase
and archetype design phase, the fifth phase consists of test,
evaluation, and review, concluded by the delivery and the
maintenance phases.
To the authors’ knowledge, two more methodologies
have been used for the design of archetypes: The AORTIS
model [50] is a general scheme for summarising clinical
information. It identifies five distinct stages: aggregation,
organisation, reduction and/or transformation, interpret-
ation, and synthesis of clinical data. Furthermore, [51]
proposed the methodology “odma” (openEHR data model-
ling approach), also used in [3]. It consists of the five steps
determining all items to be documented, merging these
items into clinical concepts, matching the derived con-
cepts against existing archetypes, developing archetypes,
and designing templates. The work concludes that the
two-layered modelling approach is a major advantage, but
it is difficult and time-consuming to develop archetypes.
Domain expertise is required. Further important de-
velopment steps are (if not already integral part of the
methodology): binding to external terminology systems,
collaboration like reviewing and publishing the archetype,
as well as adding the archetype to a template. Peer reviewed
design and modification of archetypes is a prerequisite for
high-quality models [49].
Although ADL is a sound and comprehensible formal
basis for archetype development and integrated into tool
support (e.g. CKM and Archetype Editor), we agree with
other developers (e.g. [25]) that there is a shortage of
modelling guidelines or best-practice recommendations.
How to select from a multitude of potential equivalent
models is not covered by the formal language definition.
However, it remains unclear whether such modelling
paradigms can even be described formally without theadverse effect of too limited modelling expressivity. This
case study supports the development paradigm of com-
bining a formal language definition with a regulated re-
view process to achieve a pragmatic but feasible definition
process of expressive, nevertheless standardised and inter-
operable information models.
Such a centralised and standardised review process
can also help to come across ambiguous test instructions
(as mentioned earlier), because the openEHR approach
tries to involve clinicians from the beginning of the
modelling process to ensure model consistency. Further-
more, model and style variations would probably occur
even if best-practice recommendations and modelling
guidelines were available, just because different designers
may have different approaches. Again, archetype submis-
sion to CKM and centralised review will assure align-
ment with consistent modelling methodology [35].
Limitations of the study
The results of this case report are not generalizable to
all medical information modelling methodologies. They
represent our personal experience from the development
and review of the four MSFC archetypes. In the general
topic of how to measure the quality of information models,
we assessed the archetype review process as one way to
improve the quality of the models. We do not know how
other approaches (e.g. HL7) ensure high-quality models.
Tools can cover syntactic correctness and consistency
checks. Beyond that, there are (as far as we know) only
non-quantitative indicators, such as expert opinions, the
use in clinical application (as well as the quality of docu-
mentation), as well as links to terminologies (see next sec-
tion). The assessment of all of these aspects needs to be
done by medical experts. Therefore, it is essential to in-
volve medical experts from the very beginning of the mod-
elling process, as promoted by the openEHR approach.
The general idea of rating and commenting informa-
tion models has also been implemented by Breil et al.
[52] in a portal for Medical Data Models. A large num-
ber of record forms has been collected from various
sources, and can also be imported from and exported to
multiple formats. They do not provide a structured re-
view but a simple five-star rating and comment function.
This example shows that the idea of independent quality
assessment by external experts (peer review) can be gen-
eralised to other applications outside the openEHR con-
text. However, this may request significant work and
additional research.
As far as we know, the four MSFC archetypes have not
been used in a clinical situation. So an evaluation in clinical
practice is still lacking. Recently, the archetype of the Nine
Hole Peg Test has been translated into Chinese. Neverthe-
less, we think that we provide evidence for a method and
feasibility of a structured development process for complex
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Despite these major limitations, this work can add to a cor-
pus of evidence on how to achieve a substantial amount of
validated archetypes.
Further research
A next step could be the binding to external terminolo-
gies like SNOMED CT, based on current work done by
the CIMI and the SemanticHealthNet network [42]. An-
other important aspect is the discussion about quality
criteria upon which the peer review should be based on.
One criterion could be such a consequent terminology
binding. This leads to the question of how to draw a line
between content to be expressed by information models
and content to be expressed by terminologies and ontol-
ogies, according to clear criteria [53,54].
A more thorough investigation of the lifecycle of infor-
mation models (including their clinical application) should
be done with respect to the efficiency of the review process:
Are these models invariable for a long time and is therefore
an expensive validation process justifiable? Even published
archetypes may receive frequent change requests (due to
new standards, treatments, regulatory, or terminological
changes). It is also possible that different experts could
have produced a slightly different outcome. Here, one
should investigate if there could be determined a typical
number of expert opinions to lead to a stable consent.
However, archetypes represent current clinical practice.
As such, published archetypes are not perfect, but they are
likely to be the best and most flexible models available
at present.
Furthermore, we found that some medical assessment
instructions, e.g. how a certain test should be performed,
are differing in literature. This leads to the question if a
consensus forming process, like the team review for ar-
chetypes, could help to standardise medical procedures
(bidirectional information flow).
Conclusions
Assessing the quality of information models in a standar-
dised way is an integral part of the development process.
Several approaches to represent and exchange electronic
health data are available. In a corpus of prior studies, a lot
of effort has been spent for feasibility checks, to show that
certain aspects can be represented. Now it is time to thor-
oughly investigate the quality of those models. Hereby,
clinical experts and modelling expert have to work to-
gether in a process like the one we have illustrated.
Peer review is an important part of the development
lifecycle for information models. It is crucial not only for
the quality of the models, but also for the quality of the
resulting applications and therefore patient safety. The
development and validation process is time-consuming.
However, the review can significantly improve the modelquality, so we think it is worth the effort. During the
whole development lifecycle, it is crucial to consult clinical
experts, not only during the validation of the models. The
CKM is a well-suited platform for international collabor-
ation. Once a certain amount of stable models is available,
fewer archetypes have to undergo design from scratch and
the development times may shorten.
The openEHR approach offers great expressivity and
flexibility. Although there is a shortage of modelling guide-
lines and best-practice recommendations, openEHR pro-
vides a community-driven validation process, which can
partly fill the gap. In particular, the review process is a prag-
matic way in achieving high-quality information models by
integrating domain specialists.
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